Passage Bio Statistics
NASDAQ: PASGHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
3.78-0.075 (-1.95%)
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Passage Bio by the numbers
Passage Bio has a market capitalization of $12.2 million based on 3.22M shares outstanding. With trailing EPS of $-11.33, Passage Bio is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 17.3% below its 50-day average and 46.7% below its 200-day average.
Average daily trading volume is 26.11K shares, or about $98,684 in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
PASG valuation vs. peer median
| Metric | PASG | Peer median | Difference |
|---|---|---|---|
| Market cap | $12.16M | $13.11M | -7% |
| Avg. volume | 26.11K | 241.98K | -89% |
Peer median across 8 companies: PLUR, INTS, INAB, SNTI, TCRX, BCDA, AIM, DYAI.
Valuation
- Market cap
- $12.16M
- EPS (TTM)
- $-11.33
- Shares outstanding
- 3.22M
Price and trading
- Previous close
- 3.86
- Open
- 3.77
- Day range
- 3.63 – 3.83
- 52-week range
- 3.29 – 20.00
- 52-week change
- -54.35%
- Beta
- —
- Volume
- 15.45K
- Average volume
- 26.11K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Mar 3, 2026
Additional statistics
- Market Cap
- 12.16M
- Forward Pe
- -0.36
- Eps
- -11.33
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 20.00
- Week52 Low
- 3.29
- Avg Volume
- 26,107.00
- Shares Outstanding
- 3.22M
- Ma50
- 4.57
- Ma200
- 7.09
- Earnings Date
- Mar 3, 2026
- Pct From52w High
- -81.10%
- Pct From52w Low
- 14.89%